A comparison of in vitro methods for determining the membrane receptor expression in cell lines.

INTRODUCTION Determining the number of expressed receptors per cell (NRPC) in cell lines is an important prerequisite for many experimental procedures in biomedical research. This paper focuses on the comparison of a newly developed method of determining NRPC - the Kinetic extrapolation method (KEX) - with the standard saturation method. These two methods, both based on radiolabeled ligand-receptor binding, were compared with the data on receptor expression found using quantified western blotting. METHODS Four cell lines with different expressions of epidermal growth factor receptor (EGFR) were chosen for the experiment: A431, HaCaT, HCT116 and HepG2. Two radiolabeled monoclonal antibodies specific for EGFR were used as ligands: [(131)I]-cetuximab and [(131)I]-panitumumab. The classic manual technique based on the saturation of cell receptors was performed on cells seeded in 24-well plates. The KEX method uses the LigandTracer, a special instrument which detects ligand retention in real time from seeded cells onto a rotating Petri dish. The western blot analysis was performed according to the routinely used procedure. RESULTS A very close accordance between the manual saturation technique and the KEX method was found in all four cell lines used. The NRPC in the cell lines follows the same order using both ligands: A431>HaCaT>HCT116≈HepG2. Similarly, consistent data on EGFR expression in the studied cell lines were obtained using western blot analysis and the radiolabeled ligand binding assays. CONCLUSIONS The KEX method could be as similarly useful for determining receptor expression as is the classic saturation method and western blotting.

[1]  Karl Andersson,et al.  Real-time immunohistochemistry analysis of embedded tissue. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  Karl Andersson,et al.  Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[3]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[4]  Karl Andersson,et al.  Avoiding false negative results in specificity analysis of protein–protein interactions , 2011, Journal of molecular recognition : JMR.

[5]  E. Raymond,et al.  Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma. , 2005, European journal of cancer.

[6]  E. Maccaroni,et al.  Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer , 2010, Core evidence.

[7]  H. Lundqvist,et al.  Characterization of 111In and 177Lu‐labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay , 2008, Journal of molecular recognition : JMR.

[8]  B. Angus,et al.  Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay. , 1994, Cytometry.

[9]  H Nakajima,et al.  Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.

[10]  Karl Andersson,et al.  Automated, high-resolution cellular retention and uptake studies in vitro. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[11]  W. Hanna Testing for HER2 Status , 2001, Oncology.

[12]  S. Chang,et al.  Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. , 2009, Cancer letters.

[13]  H. Lenz,et al.  EGFR Signaling and Drug Discovery , 2010, Oncology.

[14]  Masters,et al.  Cell line misidentification: the beginning of the end , 2010 .

[15]  Karl Andersson,et al.  Circumventing the requirement of binding saturation for receptor quantification using interaction kinetic extrapolation , 2011, Nuclear medicine communications.

[16]  M. Trevethick,et al.  Ligand binding assays at equilibrium: validation and interpretation , 2010, British journal of pharmacology.